36 research outputs found

    Efeitos da aplicação de retardador (CCC) e acelerador (GA) de crescimento na morfologia e produtividade do feijoeiro (Phaseolus vulgaris L. cv. Carioca)

    Get PDF
    Verificou-se os efeitos de CCC e GA quando aplicados sob a forma de pulverização das plântulas, na morfologia, florescimento e produtividade do feijoeiro cultivar Carioca, em condições de casa de vegetação. Estudou-se as concentrações de 500, 2000 e 4000 ppm de CCC juntamente com 50 pprn de GA; sendo que CCC 500 + GA 50 ppm promoveu aceleração no crescimento da haste principal e CCC 4000 + GA 50 ppm retardou esse crescimento em relação ao controle. Aplicação de CCC 500 + GA 50 ppm aumentou o número de folhas do feijoeiro. Num período de 2 semanas após o tratamento com CCC 500 + GA 50 ppm ocorreu aumento no comprimento dos meritalos, sendo que 30 dias após a aplicação de CCC 4000 + GA 50 ppm verificou-se diminuição no comprimento dos mesmos. Observou-se aumento no comprimento do limbo foliar 5 dias após os tratamentos com CCC 500 + GA 50 ppm ou CCC 2000 + GA 50 ppm. Ocorreu aumento no número médio de flores com aplicação de CCC 500 + GA 50 ppm. Não ocorreram diferenças significativas entre a produtividade das plantas tratadas com relação ao controle.In this paper the autors tested the effects of (2 - chloroethyl) trimethylammonium chloride (CCC) and gibberellic acid (GA) on the cultivar Carioca of bean, in three different concentrations (500, 2000, and 4000 ppm) of CCC and one concentration of GA (50 ppm). Treatment with CCC 500 ppm + GA 50 ppm increased the height of bean plant and CCC 4000 ppm + GA 50 ppm reduced the height of Phaseolus vulgaris. Application of CCC 500 ppm + GA 50 ppm or CCC 2000 ppm + GA 50 ppm increased the leaf number of bean plant. CCC 500 ppm + GA 50 ppm promoted a increase in the internode length and CCC 4000 ppm + GA 50 ppm reduced the length of internodcs. Application of CCC 500 ppm + GA 50 ppm or CCC 2000 ppm + GA 50 ppm increased the leaf length 5 days after the treatment. CCC 500 ppm + GA 50 ppm promoted higher flowering in relation to the check.

    An organelle-specific protein landscape identifies novel diseases and molecular mechanisms

    Get PDF
    Contains fulltext : 158967.pdf (publisher's version ) (Open Access)Cellular organelles provide opportunities to relate biological mechanisms to disease. Here we use affinity proteomics, genetics and cell biology to interrogate cilia: poorly understood organelles, where defects cause genetic diseases. Two hundred and seventeen tagged human ciliary proteins create a final landscape of 1,319 proteins, 4,905 interactions and 52 complexes. Reverse tagging, repetition of purifications and statistical analyses, produce a high-resolution network that reveals organelle-specific interactions and complexes not apparent in larger studies, and links vesicle transport, the cytoskeleton, signalling and ubiquitination to ciliary signalling and proteostasis. We observe sub-complexes in exocyst and intraflagellar transport complexes, which we validate biochemically, and by probing structurally predicted, disruptive, genetic variants from ciliary disease patients. The landscape suggests other genetic diseases could be ciliary including 3M syndrome. We show that 3M genes are involved in ciliogenesis, and that patient fibroblasts lack cilia. Overall, this organelle-specific targeting strategy shows considerable promise for Systems Medicine

    SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

    Get PDF
    BACKGROUND: Most studies of immunity to SARS-CoV-2 focus on circulating antibody, giving limited insights into mucosal defences that prevent viral replication and onward transmission. We studied nasal and plasma antibody responses one year after hospitalisation for COVID-19, including a period when SARS-CoV-2 vaccination was introduced. METHODS: In this follow up study, plasma and nasosorption samples were prospectively collected from 446 adults hospitalised for COVID-19 between February 2020 and March 2021 via the ISARIC4C and PHOSP-COVID consortia. IgA and IgG responses to NP and S of ancestral SARS-CoV-2, Delta and Omicron (BA.1) variants were measured by electrochemiluminescence and compared with plasma neutralisation data. FINDINGS: Strong and consistent nasal anti-NP and anti-S IgA responses were demonstrated, which remained elevated for nine months (p < 0.0001). Nasal and plasma anti-S IgG remained elevated for at least 12 months (p < 0.0001) with plasma neutralising titres that were raised against all variants compared to controls (p < 0.0001). Of 323 with complete data, 307 were vaccinated between 6 and 12 months; coinciding with rises in nasal and plasma IgA and IgG anti-S titres for all SARS-CoV-2 variants, although the change in nasal IgA was minimal (1.46-fold change after 10 months, p = 0.011) and the median remained below the positive threshold determined by pre-pandemic controls. Samples 12 months after admission showed no association between nasal IgA and plasma IgG anti-S responses (R = 0.05, p = 0.18), indicating that nasal IgA responses are distinct from those in plasma and minimally boosted by vaccination. INTERPRETATION: The decline in nasal IgA responses 9 months after infection and minimal impact of subsequent vaccination may explain the lack of long-lasting nasal defence against reinfection and the limited effects of vaccination on transmission. These findings highlight the need to develop vaccines that enhance nasal immunity. FUNDING: This study has been supported by ISARIC4C and PHOSP-COVID consortia. ISARIC4C is supported by grants from the National Institute for Health and Care Research and the Medical Research Council. Liverpool Experimental Cancer Medicine Centre provided infrastructure support for this research. The PHOSP-COVD study is jointly funded by UK Research and Innovation and National Institute of Health and Care Research. The funders were not involved in the study design, interpretation of data or the writing of this manuscript

    Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease

    Get PDF
    One in ten severe acute respiratory syndrome coronavirus 2 infections result in prolonged symptoms termed long coronavirus disease (COVID), yet disease phenotypes and mechanisms are poorly understood1. Here we profiled 368 plasma proteins in 657 participants ≥3 months following hospitalization. Of these, 426 had at least one long COVID symptom and 233 had fully recovered. Elevated markers of myeloid inflammation and complement activation were associated with long COVID. IL-1R2, MATN2 and COLEC12 were associated with cardiorespiratory symptoms, fatigue and anxiety/depression; MATN2, CSF3 and C1QA were elevated in gastrointestinal symptoms and C1QA was elevated in cognitive impairment. Additional markers of alterations in nerve tissue repair (SPON-1 and NFASC) were elevated in those with cognitive impairment and SCG3, suggestive of brain–gut axis disturbance, was elevated in gastrointestinal symptoms. Severe acute respiratory syndrome coronavirus 2-specific immunoglobulin G (IgG) was persistently elevated in some individuals with long COVID, but virus was not detected in sputum. Analysis of inflammatory markers in nasal fluids showed no association with symptoms. Our study aimed to understand inflammatory processes that underlie long COVID and was not designed for biomarker discovery. Our findings suggest that specific inflammatory pathways related to tissue damage are implicated in subtypes of long COVID, which might be targeted in future therapeutic trials

    Efeito do cloreto de chlormequat sobre quatro cultivares de trigo em duas épocas de semeadura Effect of chlormequat chloride on four wheat cultivars on two sowing dates

    No full text
    Dois experimentos foram conduzidos visando avaliar o efeito do Cloreto de chlormequat (CCC), aplicado em duas épocas de semeadura, sobre o rendimento de grãos e outras características de quatro cultivares de trigo. Os tratamentos foram as cultivares CEP 19, BR 14, BR 15 e BR 23. As doses de CCC foram de 400g ia/ha em 1989 e 1000g ia/ha em 1990 e as datas de semeadura foram em junho e julho. A característica afetada pelo CCC foi altura de plantas, sendo que o regulador de crescimento não afetou o rendimento de grãos. Conclui-se que outros estudos devem ser feitos para verificar quais os fatores que determinam respostas positivas à aplicação deste regulador de crescimento.<br>Two experiments were conducted aiming to evaluate the effects of the growth regulator CCC [2-Chioroethyl,trimethylammonium chloride] on seed yield and other characteristics of four wheat cultivars on two seeding dates. The treatments were the cultivars CEP 19, BR 14, BR 15 and BR 23 and the CCC doses 400 and 1000g ai/ha in 1989 and 1990 respectively. The seeding dates were in June and July. The only effect observed was a reduction in plant height but there was no increase in grain yield. It was concluded that further studies showld be carried out in order to determine the factors that affect the response of the wheat plant to this growth regulator
    corecore